Although melatonin has been shown to activate the TGF-β1 pathway related to growth inhibition of breast cancer cells [41], we observed an antagonizing effect of melatonin on TGF-β1 and VEGF levels in the course of OC treatment. Here, VEGFA is linked to breast carcinoma.